Clinical Trials Sponsored by Evan Fertig

Total 1548 results

Ferring Pharmaceuticals

Completed

A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia

Nocturia

Czech Republic
Ferring Pharmaceuticals

Completed

Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation

Chronic Idiopathic Constipation

United States, Belgium, Canada, Czech Republic, Hungary, Poland, Slovakia, South Africa, Sweden, United Kingdom
Ferring Pharmaceuticals

Completed

Canadian Active & Maintenance Modified Pentasa Study (CAMMP)

Active Ulcerative Colitis | Remission of Ulcerative Colitis

Canada
Ferring Pharmaceuticals

Completed

A Study Comparing Picoprep With Mannitol and Bisacodyl for Colon Cleansing in Preparation for Colonoscopy (CLEAR PREP)

Bowel Preparation

Brazil
Ferring Pharmaceuticals

Completed

Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia

Nocturia

Canada, United States
Ferring Pharmaceuticals

Completed

Prospective, Longitudinal Multicentric Survey in the Therapeutic Care of Mild to Moderate Ulcerative Colitis (OPTIMUM)

Ulcerative Colitis

France
Ferring Pharmaceuticals

Completed

Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients

Nocturia

United States, Canada
Ferring Pharmaceuticals

Completed

Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients (COMFORT)

Nocturia

United States, Canada
Ferring Pharmaceuticals

Completed

Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females (Compass)

Anovulation

China
Ferring Pharmaceuticals

Terminated

Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device (ZOMAXEPT)

Growth Hormone Deficiency | Turner's Syndrome

France
Ferring Pharmaceuticals

Terminated

Daytime Impact Sleep Study (DAISS)

Nocturia

United Kingdom
Ferring Pharmaceuticals

Completed

A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment

Luteal Hormone Supplementation

Japan
Ferring Pharmaceuticals

Completed

Intermittent Treatment With Degarelix of Patients Suffering From Prostate Cancer

Prostate Cancer

Spain, Netherlands, Belgium, Italy, France, Germany
Ferring Pharmaceuticals

Completed

Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation (FACT)

Prostate Cancer

France
Ferring Pharmaceuticals

Completed

Misoprostol Vaginal Insert (MVI) 100, 150, 200 mcg for Cervical Ripening and Induction of Labor

Induction of Labor | Cervical Ripening

United States
Ferring Pharmaceuticals

Completed

Post Marketing Surveillance of MENOPUR

Infertility

Korea, Republic of
Ferring Pharmaceuticals

Completed

Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients

Prostate Cancer

Belgium, Italy, Sweden, Portugal, Denmark, Finland, Norway, Turkey
Ferring Pharmaceuticals

Terminated

Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer

Prostate Cancer

Spain, United Kingdom, Germany
Ferring Pharmaceuticals

Withdrawn

Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton®

Growth Hormone Deficiency
Ferring Pharmaceuticals

Completed

A Long Term Safety Study of Degarelix in Patients With Prostate Cancer

Prostate Cancer

Spain, France, Belgium, Italy, Sweden, Portugal, Turkey
Ferring Pharmaceuticals

Completed

The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

Prostate Cancer

United States, Canada, Czech Republic, Germany, Hungary, Mexico, Netherlands, Puerto Rico, Romania, Russian Federation, Ukraine, United Kingdom
Ferring Pharmaceuticals

Completed

Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Day Before PicoPrep

Bowel Preparation

United States
Ferring Pharmaceuticals

Completed

Follow-up of Glypressin (Terlipressin) Clinical Efficacy in the Treatment of Bleeding Oesophageal Varices

Gastrointestinal Bleeding | Oesophageal Varices

Romania
Ferring Pharmaceuticals

Completed

Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer

Prostate Cancer

Spain, France, United States, Greece, United Kingdom, Germany, Netherlands
Ferring Pharmaceuticals

Completed

A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation

Constipation

China
Ferring Pharmaceuticals

Terminated

Open Label Comparative Trial of Dinoprostone Plus or Minus Oxytocin Versus Oxytocin Alone in Cervical Ripening for Labor Induction (SOFTNES)

Cesarean Section | Vaginal Delivery

Brazil
Ferring Pharmaceuticals

Completed

Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease (CD05)

Crohn's Disease

United States, Netherlands, Israel, Belgium, Germany
Ferring Pharmaceuticals

Completed

A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).

Central Diabetes Insipidus

Japan
Ferring Pharmaceuticals

Completed

A Study of Zomacton in Children With Growth Hormone Deficiency

Growth Hormone Deficiency

Israel, Hungary, India, Ukraine, Poland, Romania, Russian Federation
Ferring Pharmaceuticals

Completed

Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor

Labor, Induced | Cervical Ripening

United States, Canada
Ferring Pharmaceuticals

Completed

Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour

Cervical Ripening | Labor Induction

United Kingdom
Ferring Pharmaceuticals

Terminated

A Study With Pentasa in Patients With Active Crohn's Disease (PEACE)

Crohn´s Disease

United Kingdom, United States, Germany, Belgium, Denmark, France, Sweden
Ferring Pharmaceuticals

Terminated

The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"

Crohn's Disease

Sweden
Ferring Pharmaceuticals

Completed

A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer

Prostate Cancer

United States, Canada
Ferring Pharmaceuticals

Completed

Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486

Prostate Cancer

United States
Ferring Pharmaceuticals

Terminated

Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients

Prostate Cancer

United States
Ferring Pharmaceuticals

Completed

Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)

Fertility
Ferring Pharmaceuticals

Completed

Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission

Ulcerative Colitis

Sweden, Netherlands, Denmark, Belgium, Finland, Czech Republic, Germany, Norway
Ferring Pharmaceuticals

Completed

A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease

Crohn's Disease

Czech Republic
Ferring Pharmaceuticals

Completed

Efficacy and Safety Study of XP12B in Women With Menorrhagia

Menorrhagia | Heavy Menstrual Bleeding

United States
Ferring Pharmaceuticals

Completed

A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer

Prostate Cancer

United States, Belgium, Netherlands, Canada, Russian Federation, Finland, Former Serbia and Montenegro, France, Germany, Romania, United Kingdom
Ferring Pharmaceuticals

Completed

Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer

Prostate Cancer

United States, Canada
Ferring Pharmaceuticals

Completed

A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa

Infertility

Germany, United Kingdom
Elan Pharmaceuticals

Terminated

A Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis
Elan Pharmaceuticals

Completed

Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain

Pain

United States
Elan Pharmaceuticals

Terminated

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis

United States, Canada
Elan Pharmaceuticals

Completed

A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache

Migraine Headache

United States
Elan Pharmaceuticals

Completed

Prialt (Ziconotide) In Severe Chronic Pain

Pain

United States
Elan Pharmaceuticals

Completed

Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.

Stroke | Multiple Sclerosis | Muscle Spasticity | Spinal Cord Injury

United States
Elan Pharmaceuticals

Terminated

Open-label Adjunctive Zonisamide for Bipolar Disorder

Bipolar Disorders

3

Subscribe